Therefore, decreased mPFC taurine levels might limit the defensive capabilities of mPFC neurons and NAC could potentially compensate for this loss by enhancing GSH synthesis and rebalancing the local redox system
Keeping an eye on how its going and making changes is key to success
10.1021/cr990071k 150 DoolittleR
Human clinical-trial data (Phase 1/2 studies in wound healing, cardiac injury, and dry eye) exist only for a different, full-length recombinant thymosin beta-4 product, not for the short synthetic fragment marketed as TB-500, so no completed published human trial has evaluated TB-500 specifically for muscle, tendon, or joint recovery
Because as of 2025 we do not have a method to alter your DNA that is genetically determined, much like how we cant alter height or IQ